These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22380808)

  • 1. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection.
    Bragg RF; Duffy AL; DeCecco FA; Chung DK; Green MT; Veir JK; Dow SW
    J Am Vet Med Assoc; 2012 Mar; 240(6):700-4. PubMed ID: 22380808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection.
    Iris Kalli ; Leontides LS; Mylonakis ME; Adamama-Moraitou K; Rallis T; Koutinas AF
    Res Vet Sci; 2010 Oct; 89(2):174-8. PubMed ID: 20303134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of hyperimmune plasma for treatment of dogs with naturally occurring parvoviral enteritis.
    Acciacca RA; Sullivan LA; Webb TL; Johnson V; Dow SW
    J Vet Emerg Crit Care (San Antonio); 2020 Sep; 30(5):525-533. PubMed ID: 32705762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune plasma for treatment of parvoviral gastroenteritis.
    Dodds WJ
    J Am Vet Med Assoc; 2012 May; 240(9):1056; author reply 1056. PubMed ID: 22641872
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection.
    Proksch AL; Unterer S; Truyen U; Hartmann K
    Vet J; 2014 Nov; 202(2):340-7. PubMed ID: 25218850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic changes associated with fluid resuscitation in canine parvoviral enteritis.
    Whitehead Z; Goddard A; Botha WJ; Pazzi P
    J S Afr Vet Assoc; 2020 Jul; 91(0):e1-e9. PubMed ID: 32787422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of canine parvovirus-2 in Albania.
    Kusi I
    Dtsch Tierarztl Wochenschr; 1997 Nov; 104(11):478-80. PubMed ID: 9429323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991).
    Houston DM; Ribble CS; Head LL
    J Am Vet Med Assoc; 1996 Feb; 208(4):542-6. PubMed ID: 8603904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breed-related risk factors for canine parvovirus enteritis.
    Glickman LT; Domanski LM; Patronek GJ; Visintainer F
    J Am Vet Med Assoc; 1985 Sep; 187(6):589-94. PubMed ID: 3003015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of canine parvovirus type 2c in the dogs with haemorrhagic enteritis in India.
    Nandi S; Chidri S; Kumar M; Chauhan RS
    Res Vet Sci; 2010 Feb; 88(1):169-71. PubMed ID: 19552931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathologic features of parvoviral diarrhea in pound-source dogs.
    Stann SE; DiGiacomo RF; Giddens WE; Evermann JF
    J Am Vet Med Assoc; 1984 Sep; 185(6):651-5. PubMed ID: 6092314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of oseltamivir in the treatment of canine parvoviral enteritis.
    Savigny MR; Macintire DK
    J Vet Emerg Crit Care (San Antonio); 2010 Feb; 20(1):132-42. PubMed ID: 20230441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of canine parvovirus infection in dogs.
    Kilian E; Suchodolski JS; Hartmann K; Mueller RS; Wess G; Unterer S
    PLoS One; 2018; 13(3):e0192198. PubMed ID: 29547647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial.
    Otto CM; Jackson CB; Rogell EJ; Prior RB; Ammons WS
    J Vet Intern Med; 2001; 15(4):355-60. PubMed ID: 11467593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
    Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
    J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the use of antiemetic agents in dogs with parvoviral enteritis treated at a veterinary teaching hospital: 77 cases (1997-2000).
    Mantione NL; Otto CM
    J Am Vet Med Assoc; 2005 Dec; 227(11):1787-93. PubMed ID: 16342528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Canine parvovirus infection in dogs: a consideration].
    Rimmelzwaan GF; Uytdenhaag FG; Osterhaus AD
    Tijdschr Diergeneeskd; 1986 Sep; 111(18):847-59. PubMed ID: 3020734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple tests for rapid detection of canine parvovirus antigen and canine parvovirus-specific antibodies.
    Marulappa SY; Kapil S
    Clin Vaccine Immunol; 2009 Jan; 16(1):127-31. PubMed ID: 18987166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, molecular characterization and phylogenetic analysis of canine parvovirus.
    Mohan Raj J; Mukhopadhyay HK; Thanislass J; Antony PX; Pillai RM
    Infect Genet Evol; 2010 Dec; 10(8):1237-41. PubMed ID: 20723622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.